Matches in SemOpenAlex for { <https://semopenalex.org/work/W1985158488> ?p ?o ?g. }
- W1985158488 endingPage "206" @default.
- W1985158488 startingPage "197" @default.
- W1985158488 abstract "Human apolipoprotein E (apoE) is a 34.2kDa glycosylated protein with three isoforms (apoE2, apoE3 and apoE4). Experimental autoimmune neuritis (EAN), an animal model for human Guillain-Barré syndrome, is an immune-mediated experimental disorder of the peripheral nervous system (PNS). Increased susceptibility to EAN in apoE deficient mice has been previously found. To elucidate the isoform-dependent effects of apoE on EAN, we used human apoE2, E3 and E4 transgenic mice (Tg) immunized with P0 peptide 180-199, as well as T cell proliferation test, macrophage and Schwann cell (SC) cultures to investigate the effects of apoE isoforms on the functions of T cells, macrophages and SCs both under naïve conditions and in EAN. Clinical signs of EAN were most severe in wild type (WT) C57BL/6 mice and apoE4 Tg mice, followed by apoE2 Tg mice and apoE3 Tg mice (WT≈E4>E2>E3, p<0.01). At the nadir of EAN, spleen weight and lymphocyte proliferation were in line with the clinical severity of the disease. Proliferation tests of purified T cells from naive mice stimulated with phytohemagglutinin or interleukin-12 showed isoform-specific differences (WT≈E4>E3≈E2, p<0.01). Macrophages from both naïve and EAN mice produced nitric oxide upon inflammatory stimulation with lipopolysaccharide, interferon-γ, polyinosinic:polycytidylic acid or combinations thereof, in an isoform-dependent manner (WT≈E4>E2>E3, p<0.01). Generalized intervention with 1400W, a specific inducible nitric oxide synthase inhibitor, significantly suppressed the clinical course of EAN in apoE2, E3 and E4 Tg mice and in WT mice. During the recovery stage of disease, the highest expression of CD178 (FasL) on SCs was found in apoE3 Tg mice. Our data support an isoform-dependent effect of apoE on EAN. This might be due to the isoform-specific effects of apoE on functions of T cells, macrophages and SCs, which contribute to the distinct clinical courses of EAN. ApoE3 might not only inhibit the onset and suppress the clinical severity of EAN, but also enhance the termination of immune responses in the PNS." @default.
- W1985158488 created "2016-06-24" @default.
- W1985158488 creator A5015483602 @default.
- W1985158488 creator A5032021152 @default.
- W1985158488 creator A5037897129 @default.
- W1985158488 creator A5038816790 @default.
- W1985158488 creator A5050209085 @default.
- W1985158488 creator A5071871570 @default.
- W1985158488 creator A5075987263 @default.
- W1985158488 creator A5081228016 @default.
- W1985158488 date "2011-08-01" @default.
- W1985158488 modified "2023-10-03" @default.
- W1985158488 title "APOE ε3 attenuates experimental autoimmune neuritis by modulating T cell, macrophage and Schwann cell functions" @default.
- W1985158488 cites W1629602451 @default.
- W1985158488 cites W1736154854 @default.
- W1985158488 cites W1837896746 @default.
- W1985158488 cites W1984736956 @default.
- W1985158488 cites W1989668711 @default.
- W1985158488 cites W1998699294 @default.
- W1985158488 cites W1999742425 @default.
- W1985158488 cites W2003508635 @default.
- W1985158488 cites W2005246739 @default.
- W1985158488 cites W2012347097 @default.
- W1985158488 cites W2018109459 @default.
- W1985158488 cites W2021168602 @default.
- W1985158488 cites W2021547032 @default.
- W1985158488 cites W2033173787 @default.
- W1985158488 cites W2034968148 @default.
- W1985158488 cites W2039424198 @default.
- W1985158488 cites W2044113412 @default.
- W1985158488 cites W2068156076 @default.
- W1985158488 cites W2069121057 @default.
- W1985158488 cites W2077249332 @default.
- W1985158488 cites W2087360247 @default.
- W1985158488 cites W2088526201 @default.
- W1985158488 cites W2096142564 @default.
- W1985158488 cites W2102889754 @default.
- W1985158488 cites W2125996621 @default.
- W1985158488 cites W2127831086 @default.
- W1985158488 cites W2136442779 @default.
- W1985158488 cites W2139754661 @default.
- W1985158488 cites W2141328060 @default.
- W1985158488 cites W2144076105 @default.
- W1985158488 cites W2144373514 @default.
- W1985158488 cites W2164449928 @default.
- W1985158488 cites W2310137032 @default.
- W1985158488 cites W3148579587 @default.
- W1985158488 doi "https://doi.org/10.1016/j.expneurol.2011.04.016" @default.
- W1985158488 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21550340" @default.
- W1985158488 hasPublicationYear "2011" @default.
- W1985158488 type Work @default.
- W1985158488 sameAs 1985158488 @default.
- W1985158488 citedByCount "8" @default.
- W1985158488 countsByYear W19851584882012 @default.
- W1985158488 countsByYear W19851584882013 @default.
- W1985158488 countsByYear W19851584882014 @default.
- W1985158488 countsByYear W19851584882016 @default.
- W1985158488 crossrefType "journal-article" @default.
- W1985158488 hasAuthorship W1985158488A5015483602 @default.
- W1985158488 hasAuthorship W1985158488A5032021152 @default.
- W1985158488 hasAuthorship W1985158488A5037897129 @default.
- W1985158488 hasAuthorship W1985158488A5038816790 @default.
- W1985158488 hasAuthorship W1985158488A5050209085 @default.
- W1985158488 hasAuthorship W1985158488A5071871570 @default.
- W1985158488 hasAuthorship W1985158488A5075987263 @default.
- W1985158488 hasAuthorship W1985158488A5081228016 @default.
- W1985158488 hasConcept C126322002 @default.
- W1985158488 hasConcept C134018914 @default.
- W1985158488 hasConcept C153911025 @default.
- W1985158488 hasConcept C185592680 @default.
- W1985158488 hasConcept C203014093 @default.
- W1985158488 hasConcept C2776090121 @default.
- W1985158488 hasConcept C2778754761 @default.
- W1985158488 hasConcept C2779134260 @default.
- W1985158488 hasConcept C57089818 @default.
- W1985158488 hasConcept C71924100 @default.
- W1985158488 hasConcept C86803240 @default.
- W1985158488 hasConcept C8891405 @default.
- W1985158488 hasConceptScore W1985158488C126322002 @default.
- W1985158488 hasConceptScore W1985158488C134018914 @default.
- W1985158488 hasConceptScore W1985158488C153911025 @default.
- W1985158488 hasConceptScore W1985158488C185592680 @default.
- W1985158488 hasConceptScore W1985158488C203014093 @default.
- W1985158488 hasConceptScore W1985158488C2776090121 @default.
- W1985158488 hasConceptScore W1985158488C2778754761 @default.
- W1985158488 hasConceptScore W1985158488C2779134260 @default.
- W1985158488 hasConceptScore W1985158488C57089818 @default.
- W1985158488 hasConceptScore W1985158488C71924100 @default.
- W1985158488 hasConceptScore W1985158488C86803240 @default.
- W1985158488 hasConceptScore W1985158488C8891405 @default.
- W1985158488 hasIssue "2" @default.
- W1985158488 hasLocation W19851584881 @default.
- W1985158488 hasLocation W19851584882 @default.
- W1985158488 hasOpenAccess W1985158488 @default.
- W1985158488 hasPrimaryLocation W19851584881 @default.
- W1985158488 hasRelatedWork W2136518857 @default.
- W1985158488 hasRelatedWork W2145943006 @default.
- W1985158488 hasRelatedWork W2148711924 @default.